Esophageal Squamous Cell Carcinoma, Post operative Recurrence and Machine Learning

Esophageal squamous cell carcinoma (ESCC) is a common and aggressive form of cancer, with a high risk of postoperative recurrence. Accurate prediction of recurrence is essential for optimizing follow-up care and tailoring treatment strategies to improve patient outcomes. Traditional models for predicting overall survival in ESCC often lack focus on postoperative recurrence, which is a critical factor affecting long-term survival.

A recent study developed and validated a machine learning model based on support vector machines (SVM) to predict postoperative recurrence in ESCC patients. The study analyzed clinical data from 310 patients who underwent surgery, using preoperative, intraoperative, and postoperative variables such as tumor markers, inflammatory markers, TNM stage, and complications. Key risk factors identified included age, ECOG performance status, neutrophil-to-lymphocyte ratio (NLR), C-reactive protein-to-prealbumin ratio (CPR), CY211, TNM stage, and postoperative complications.

The best-performing model, SVM6+8, achieved high sensitivity (94% in the test cohort) and strong predictive accuracy. A nomogram based on the SVM6+TNM model was developed to estimate 1-, 3-, and 5-year disease-free survival (DFS). Kaplan-Meier survival analysis showed significantly improved DFS in low-risk patients.

This machine learning approach provides clinicians with a reliable tool to stratify patients into high- and low-risk groups, enabling personalized follow-up schedules and adjuvant therapy planning. While the study demonstrated robust internal validation, external validation is needed to confirm its generalizability. Nonetheless, the integration of machine learning with clinical data represents a significant advancement in ESCC management.